Send feedback

TEK p.Val86Ile

c.256G>A · rs759283621 · VCV2260009

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1703 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00203%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
multiple cutaneous and mucosal venous malformations

Computational evidence

Protein change
AlphaMissense0.1703likely benign
REVEL0.356indeterminate
SaProtLLR -6.22tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.9, phastCons 1
Regional constrainto/e 0.81unconstrained · MANE · 76 kb · p 8.9e-06 · regional, not allelic
Overall
CADD23.8PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00203% European (non-Finnish) · 24/1,179,994 alleles
Filtering AF 0.00138% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00116%
Overall 0.0018% 29/1,614,074 alleles · very rare exomes 29/1,461,882 · genomes 0/152,192 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,837
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,608
European (non-Finnish)grpmax 0.00203% 49,166
African / African-American 0.00133% 75,004

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TEK
Protein
p.Val86Ile
Coding
c.256G>A
MANE Select
NM_000459
dbSNP
rs759283621
Type
single nucleotide variant
Location
chr9:27158034 (GRCh38)
Gene constraint
LOEUF 0.368 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 84.37 · 17 PDB
Residue 86
a UniProt-annotated variant site (in glc3e; formation of protein aggregates); the ig-like c2-type 1 domain; a β-strand
Full TEK gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tek-p-val86ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown